Alzheimer Center Amsterdam University medical Center
Neurology
Prof. dr. Philip Scheltens studied at the VU University Amsterdam, Netherlands, gaining his MD in 1984, and PhD in 1993. Clinical residencies in neurosurgery and neurology supported his academic development. He is Professor of Cognitive Neurology and founder of the Alzheimer Center at Amsterdam University Medical Centers. Currently his main activity is managing partner of the LSP Dementia Fund, that he started in 2020. He has been the (inter)national PI for over 35 studies, including phase 1-3 multicenter clinical trials. He supervised >75 PhD theses since 2000. He founded the Dutch national plan against dementia and served as chair of the board. He is co-editor-in-chief of Alzheimer’s Research & Therapy and co-leads various EU projects. He authored over 1100 peer reviewed papers and > 75 book chapters and co-edited several major text books. He is member of the Royal Dutch Academy of Arts and Sciences (KNAW) since 2011. In 2016 he was awarded the European Grand Prix for Alzheimer’s Research. In 2020 he was Knighted in the Order of the Netherlands Lion by the King of the Netherlands. In 2021 he was elected honorary member of the European Academy of Neurology and was appointed chair of the World Dementia Council.

Moderator of 4 Sessions

Session Type
SYMPOSIUM
Date
Fri, 18.03.2022
Session Time
02:45 PM - 04:45 PM
Room
ONSITE: 112
Session Type
SYMPOSIUM
Date
Sat, 19.03.2022
Session Time
09:10 AM - 11:10 AM
Room
ONSITE: 112
SPONSORED SYMPOSIUM
Session Type
SPONSORED SYMPOSIUM
Date
Sat, 19.03.2022
Session Time
02:45 PM - 03:45 PM
Room
ONSITE PLENARY: 115-117
Session Description
Gut microbiota and Parkinson’s disease: Implications for pathogenesis and treatment-Supported by Green Valley

Session Description:

This symposium will bring together basic scientists, clinicians and medical researchers to advance our understanding of the gut-brain axis in Parkinson’s Disease (PD) and relate this to the current therapeutic strategies for PD treatment. By highlighting the latest research collaboration across the industry and academia, this symposium will stimulate insightful discussions on disease pathogenesis and cross-discipline collaborations to advance drug development for PD.

Session Type
FORUM
Date
Sat, 19.03.2022
Session Time
03:50 PM - 04:50 PM
Room
ONSITE PLENARY: 115-117

Presenter of 2 Presentations

THE LONG JOURNEY OF DRUG DEVELOPMENT IN AD: HURDLES, PITFALLS AND LESSONS LEARNED

Session Type
SYMPOSIUM
Date
Sat, 19.03.2022
Session Time
09:10 AM - 11:10 AM
Room
ONSITE: 112
Lecture Time
09:10 AM - 09:25 AM

Opening Remarks

Session Type
SPONSORED SYMPOSIUM
Date
Sat, 19.03.2022
Session Time
02:45 PM - 03:45 PM
Room
ONSITE PLENARY: 115-117
Lecture Time
02:45 PM - 02:50 PM